20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• AC Immune, Inc. ACIU shares rose 88.45% to $13.55 during Thursday's pre-market session.

• Nabriva Therapeutics, Inc. NBRV stock increased by 62.40% to $1.08.

• Lannett, Inc. LCI shares increased by 28.27% to $6.60.

• Tiziana Life Sciences, Inc. TLSA shares rose 10.42% to $9.53.

• Intec Pharma, Inc. NTEC shares moved upwards by 9.39% to $0.34.

• Veru, Inc. VERU shares increased by 7.66% to $3.37. The most recent rating by Oppenheimer, on May 14, is at Outperform, with a price target of $9.

• Adamis Pharmaceuticals, Inc. ADMP shares increased by 6.47% to $0.70. The most recent rating by Maxim Group, on May 13, is at Buy, with a price target of $2.

• NextCure, Inc. NXTC shares moved upwards by 5.10% to $9.47. The most recent rating by Benchmark, on Jul 16, is at Buy, with a price target of $17.

• Enzo Biochem, Inc. ENZ shares rose 4.39% to $2.61.

• BioNTech, Inc. BNTX stock increased by 3.97% to $81.10. The most recent rating by Canaccord Genuity, on Jul 13, is at Buy, with a price target of $75.

Losers

• Tricida, Inc. TCDA stock decreased by 33.63% to $17.39 during Thursday's pre-market session.

• INmune Bio, Inc. INMB stock fell 16.48% to $10.90. The most recent rating by HC Wainwright & Co., on Jul 15, is at Buy, with a price target of $20.

• Lianluo Smart, Inc. LLIT stock decreased by 12.40% to $0.52.

• Aptose Biosciences, Inc. APTO stock fell 11.83% to $5.52.

• VIVUS, Inc. VVUS stock decreased by 9.31% to $0.47.

• Genetic Technologies, Inc. GENE stock decreased by 8.29% to $5.20.

• Immutep, Inc. IMMP stock declined 8.22% to $1.34.

• Ocugen, Inc. OCGN shares declined 6.63% to $0.20. The most recent rating by Chardan Capital, on Jun 3, is at Buy, with a price target of $1.

• Equillium, Inc. EQ shares declined 6.24% to $16.25. The most recent rating by HC Wainwright & Co., on Jul 14, is at Buy, with a price target of $24.

• Rigel Pharmaceuticals, Inc. RIGL shares declined 5.49% to $3.10. The most recent rating by JP Morgan, on May 27, is at Overweight, with a price target of $6.